Literature DB >> 3668453

Multiple sclerosis and motor neurone disease: survival and how certified after death.

F O'Malley1, G Dean, M Elian.   

Abstract

This study assesses the outcome of a random sample of patients with multiple sclerosis (MS) and motor neurone disease (MND) selected from a previous study carried out between the years 1960 and 1972. Of the MND patients who are now dead, 20% of the women and 27% of the men lived longer than five years after hospitalised diagnosis, and two of these patients lived up to 19 years after diagnosis in hospital. Also, 10.7% of the random sample of MND patients were still alive in June 1985. Of the MS deaths 26.4% and of the MND deaths 20.4% did not have these respective conditions recorded on the death certificates.

Entities:  

Mesh:

Year:  1987        PMID: 3668453      PMCID: PMC1052568          DOI: 10.1136/jech.41.1.14

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  9 in total

1.  Survival in disseminated sclerosis: a clinical study of a series of cases first seen 20 years ago.

Authors:  R S ALLISON
Journal:  Brain       Date:  1950       Impact factor: 13.501

2.  The course of multiple sclerosis as determined by autopsy proven cases.

Authors:  S CARTER; D SCIARRA; H H MERRITT
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1950

3.  Survival and death in multiple sclerosis.

Authors:  U Leibowitz; E Kahana; M Alter
Journal:  Brain       Date:  1969-03       Impact factor: 13.501

4.  Motor neurone disease and multiple sclerosis among immigrants to Britain.

Authors:  G Dean; R Brady; H McLoughlin
Journal:  Br J Prev Soc Med       Date:  1977-09

5.  Letter: Motor-neurone disease in Israel.

Authors:  M Elian; M Artal
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

6.  General disease in 120 necropsy-proven cases of multiple sclerosis.

Authors:  I V Allen; J H Millar; M J Hutchinson
Journal:  Neuropathol Appl Neurobiol       Date:  1978 Jul-Aug       Impact factor: 8.090

7.  Multiple sclerosis among immigrants in Greater London.

Authors:  G Dean; H McLoughlin; R Brady; A M Adelstein; J Tallett-Williams
Journal:  Br Med J       Date:  1976-04-10

8.  Patient resistance and prognosis in amyotrophic lateral sclerosis.

Authors:  D W Mulder; F M Howard
Journal:  Mayo Clin Proc       Date:  1976-09       Impact factor: 7.616

9.  Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population.

Authors:  P Mortara; A Chiò; M G Rosso; M Leone; D Schiffer
Journal:  J Neurol Sci       Date:  1984 Nov-Dec       Impact factor: 3.181

  9 in total
  19 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

Review 2.  Poliovirus and motor neuron disease.

Authors:  C N Martyn
Journal:  J Neurol       Date:  1990-10       Impact factor: 4.849

3.  Do nurses or doctors have an increased risk of developing multiple sclerosis?

Authors:  G Dean; R Gray
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

Review 4.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

5.  Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis.

Authors:  Kathryn C Fitzgerald; Éilis J O'Reilly; Guido J Falcone; Marjorie L McCullough; Yikyung Park; Laurence N Kolonel; Alberto Ascherio
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

6.  The contribution of mortality statistics to the study of multiple sclerosis in Australia.

Authors:  S R Hammond; D R English; C de Wytt; J F Hallpike; K S Millingen; E G Stewart-Wynne; J G McLeod; M G McCall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

7.  Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis.

Authors:  Éilis J O'Reilly; Kjetil Bjornevik; Michael A Schwarzschild; Marjorie L McCullough; Laurence N Kolonel; Loic Le Marchand; Joann E Manson; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-12-26       Impact factor: 4.092

8.  Ecological correlates of motor neuron disease mortality: a hypothesis concerning an epidemiological association with radon gas and gamma exposure.

Authors:  S Neilson; I Robinson; F C Rose
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

9.  Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data.

Authors:  Raffaella Uccelli; Alessandra Binazzi; Pierluigi Altavista; Stefano Belli; Pietro Comba; Marina Mastrantonio; Nicola Vanacore
Journal:  Eur J Epidemiol       Date:  2007-09-14       Impact factor: 8.082

10.  Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.

Authors:  A M Chancellor; R J Swingler; H Fraser; J A Clarke; C P Warlow
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.